Zivo Bioscience, Inc. (ZIVO)
6.50
-0.01
(-0.21%)
USD |
OTCM |
Oct 16, 16:00
Zivo Bioscience EPS Diluted (Quarterly) : -0.1235 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1235 |
| March 31, 2026 | -0.2378 |
| December 31, 2025 | -0.7743 |
| September 30, 2025 | -0.2706 |
| June 30, 2025 | -0.4305 |
| March 31, 2025 | -1.123 |
| December 31, 2024 | -0.4422 |
| September 30, 2024 | -0.6652 |
| June 30, 2024 | -2.781 |
| March 31, 2024 | -0.4652 |
| December 31, 2023 | -0.9587 |
| September 30, 2023 | -1.051 |
| June 30, 2023 | -1.319 |
| March 31, 2023 | -1.257 |
| December 31, 2022 | -1.682 |
| September 30, 2022 | -1.277 |
| June 30, 2022 | -1.320 |
| March 31, 2022 | -1.292 |
| December 31, 2021 | -2.080 |
| September 30, 2021 | -1.434 |
| June 30, 2021 | -1.706 |
| March 31, 2021 | -2.558 |
| December 31, 2020 | -2.208 |
| September 30, 2020 | -4.133 |
| June 30, 2020 | -1.387 |
| Date | Value |
|---|---|
| March 31, 2020 | -3.038 |
| December 31, 2019 | -4.997 |
| September 30, 2019 | -2.458 |
| June 30, 2019 | -5.722 |
| March 31, 2019 | -8.126 |
| December 31, 2018 | -8.424 |
| September 30, 2018 | -12.13 |
| June 30, 2018 | -11.29 |
| March 31, 2018 | -13.08 |
| December 31, 2017 | -13.29 |
| September 30, 2017 | -9.826 |
| June 30, 2017 | -4.80 |
| March 31, 2017 | -4.80 |
| December 31, 2016 | -4.80 |
| September 30, 2016 | -4.80 |
| June 30, 2016 | -9.60 |
| March 31, 2016 | -4.80 |
| December 31, 2015 | -3.696 |
| September 30, 2015 | -4.80 |
| June 30, 2015 | -9.60 |
| March 31, 2015 | -4.80 |
| December 31, 2014 | 2.707 |
| September 30, 2014 | -14.40 |
| June 30, 2014 | -4.80 |
| March 31, 2014 | 14.40 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PMGC Holdings, Inc. | -60.32 |
| Shonghoya Intl Group, Inc. | 0.00 |
| TFA Therapeutics, Inc. | -- |
| Arcadia Biosciences, Inc. | -2.094 |
| CCA Industries, Inc. | -0.0219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.5125M |
| Total Expenses (Quarterly) | 0.5125M |
| Enterprise Value | 27.85M |
| Earnings Yield | -21.63% |
| Normalized Earnings Yield | -21.65 |